These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

174 related articles for article (PubMed ID: 17073649)

  • 21. RNA as a versatile and powerful platform for engineering genetic regulatory tools.
    Win MN; Smolke CD
    Biotechnol Genet Eng Rev; 2007; 24():311-46. PubMed ID: 18059640
    [No Abstract]   [Full Text] [Related]  

  • 22. Sfold web server for statistical folding and rational design of nucleic acids.
    Ding Y; Chan CY; Lawrence CE
    Nucleic Acids Res; 2004 Jul; 32(Web Server issue):W135-41. PubMed ID: 15215366
    [TBL] [Abstract][Full Text] [Related]  

  • 23. HIV-1 TAR as anchoring site for optimized catalytic RNAs.
    Puerta-Fernandez E; Barroso-del Jesus A; Romero-López C; Berzal-Herranz A
    Biol Chem; 2003 Mar; 384(3):343-50. PubMed ID: 12715885
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Rational and combinatorial strategies for designing oligonucleotides targeted to RNA structures.
    Toulmé JJ; Le Tinévez R; Boiziau C; Dausse E
    Nucleic Acids Symp Ser; 1997; (36):39-41. PubMed ID: 9478200
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Oligonucleotide libraries--variatio delectat.
    Famulok M; Jenne A
    Curr Opin Chem Biol; 1998 Jun; 2(3):320-7. PubMed ID: 9691074
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Creating RNA bulges: cleavage of RNA in RNA/DNA duplexes by metal ion catalysis.
    Hüsken D; Goodall G; Blommers MJ; Jahnke W; Hall J; Häner R; Moser HE
    Biochemistry; 1996 Dec; 35(51):16591-600. PubMed ID: 8987994
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Natural antisense RNA/target RNA interactions: possible models for antisense oligonucleotide drug design.
    Delihas N; Rokita SE; Zheng P
    Nat Biotechnol; 1997 Aug; 15(8):751-3. PubMed ID: 9255788
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Potent antisense oligonucleotides to the human multidrug resistance-1 mRNA are rationally selected by mapping RNA-accessible sites with oligonucleotide libraries.
    Ho SP; Britton DH; Stone BA; Behrens DL; Leffet LM; Hobbs FW; Miller JA; Trainor GL
    Nucleic Acids Res; 1996 May; 24(10):1901-7. PubMed ID: 8657572
    [TBL] [Abstract][Full Text] [Related]  

  • 29. In vitro selected RNA-cleaving DNA enzymes from combinatorial libraries.
    Chakraborti S; Sriram B; Banerjea AC
    Methods Mol Biol; 2004; 252():279-90. PubMed ID: 15017057
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Computer-aided calculation of the local folding potential of target RNA and its use for ribozyme design.
    Sczakiel G; Tabler M
    Methods Mol Biol; 1997; 74():11-5. PubMed ID: 9204415
    [No Abstract]   [Full Text] [Related]  

  • 31. Guidelines for Experiments Using Antisense Oligonucleotides and Double-Stranded RNAs.
    Gagnon KT; Corey DR
    Nucleic Acid Ther; 2019 Jun; 29(3):116-122. PubMed ID: 30907681
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Design and optimization of sequence-specific hairpin ribozymes.
    Romero-López C; Barroso-delJesus A; Puerta-Fernández E; Berzal-Herranz A
    Methods Mol Biol; 2004; 252():327-38. PubMed ID: 15017061
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Generation of a catalytic module on a self-folding RNA.
    Yoshioka W; Ikawa Y; Jaeger L; Shiraishi H; Inoue T
    RNA; 2004 Dec; 10(12):1900-6. PubMed ID: 15525711
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rapid identification of efficient target cleavage sites using a hammerhead ribozyme library in an iterative manner.
    Pan WH; Xin P; Bui V; Clawson GA
    Mol Ther; 2003 Jan; 7(1):129-39. PubMed ID: 12573626
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Design of hairpin ribozymes for in vitro and cellular applications.
    Yu Q; Burke JM
    Methods Mol Biol; 1997; 74():161-9. PubMed ID: 9204431
    [No Abstract]   [Full Text] [Related]  

  • 36. Effects of variations in length of hammerhead ribozyme antisense arms upon the cleavage of longer RNA substrates.
    Sioud M
    Nucleic Acids Res; 1997 Jan; 25(2):333-8. PubMed ID: 9016562
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Mapping of RNA accessible sites by extension of random oligonucleotide libraries with reverse transcriptase.
    Allawi HT; Dong F; Ip HS; Neri BP; Lyamichev VI
    RNA; 2001 Feb; 7(2):314-27. PubMed ID: 11233988
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Hybridization of antisense reagents to RNA.
    Sohail M; Southern EM
    Curr Opin Mol Ther; 2000 Jun; 2(3):264-71. PubMed ID: 11249620
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Detection of antisense and ribozyme accessible sites on native mRNAs: application to NCOA3 mRNA.
    Scherr M; LeBon J; Castanotto D; Cunliffe HE; Meltzer PS; Ganser A; Riggs AD; Rossi JJ
    Mol Ther; 2001 Nov; 4(5):454-60. PubMed ID: 11708882
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Specificity of antisense oligonucleotides in vivo.
    Woolf TM; Melton DA; Jennings CG
    Proc Natl Acad Sci U S A; 1992 Aug; 89(16):7305-9. PubMed ID: 1380154
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.